Skip to main content

Table 1 Group comparisons

From: Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation

  Up group, n = 27 Down group, n = 16  
Gender (M) 20 (74%) 10 (63%) p = 0.638
Gestational age 27.26 ± 3.59 27.25 ± 4.60 p = 0.637
Birth weight, g 992 ± 613 984 ± 663 p = 0.315
Ethnicity (n)    
 Caucasian 10 5 p = 0.185
 African American 11 3  
 Hispanic 3 6  
 Asian 1 0  
 Unknown 2 2  
Length of stay, days 129.52 ± 67.67 141.31 ± 58.11 p = 0.499
Duration of PN, days 53.96 49.63 p = 0.421
Intrauterine growth retardation (IUGR) 2 1 p = 1.00
Age at EN initiation, days 11.15 ± 13.80 24.13 ± 22.53 p = 0.037
Type of EN (n)    p = 0.573
 BM 8 3  
 Standard formula 13 11  
 Protein hydrosylate 2 0  
 Amino Acid 4 2  
Route of feeding administration (n)    p = 0.196
 PO/bolus 25 13  
 Continuous 1 0  
 Combination 1 3  
Ursodiol use (n) 19 8 p = 0.182
 Start & stop before PN cessation    
 Start before, stop after PN cessation 9 2  
 Start and stop after PN cessation 13 4  
Sepsis (n) 14 8 p = 0.578
 Occurred before PN cessation 13 5 p = 0.117
 Occurred after PN cessation 1 2  
 Occurred before and after PN cessation 0 1  
 Gram negative sepsis 5 3 p = 0.642
  Occurred before PN cessation 5 2 p = 0.375
  Occurred after PN cessation 0 1  
Rate of normalization (CB < 2 mg/dL) 16 12 p = 0.295